The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation (Q28323723)

https://api.crossref.org/works/10.1002%2FEJI.1830210228

Inositol trisphosphate and diacylglycerol as second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

FK-506--how much potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

FK 506 for liver, kidney, and pancreas transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Inhibition of the immune response by rapamycin, a new antifungal antibiotic

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Molecular cloning and overexpression of the human FK506-binding protein FKBP

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

The T11 glycoprotein is functionally linked to a calcium channel in precursor and mature T-lineage cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

The role of protein kinase C in cell surface signal transduction and tumour promotion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Identification of a monoclonal antibody specific for a murine T3 polypeptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Cell growth cycle block of T cell hybridomas upon activation with antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Expression and function of CD4 in a murine T-cell hybridoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Contingent genetic regulatory events in T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Role of the CD28 receptor in T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Dissociation of phosphoinositide hydrolysis and Ca2+ fluxes from the biological responses of a T-cell hybridoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Early signal transduction by the antigen receptor without commitment to T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Activation-driven programmed cell death and T cell receptor zeta eta expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

T cell tolerance by clonal elimination in the thymus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021

Probing Immunosuppressant Action with a Nonnatural Immunophilin Ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210228

7 January 2021